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Abstract: We present a case of coronary ectasia and LAD coronary
artery aneurysm with angiographic characteristics of Kawasaki disease
in a three-yr-old girl two-yr status post-orthotopic heart transplant.
Coronary anomalies were noted during initial screening coronary
angiography two yr after transplant. Subsequent review of the donor
echocardiogram revealed that the LMCA had been mildly dilated prior
to transplant. In the absence of any symptoms consistent with
Kawasaki disease in the transplant recipient, this appears to be a case
of Kawasaki disease in the organ donor manifesting with coronary
anomalies in the transplant recipient. The patient has done well
clinically, and repeat coronary angiography has revealed partial
regression of coronary anomalies. Given multiple reports in the
literature of persistent abnormalities of coronary artery morphology
and function after Kawasaki disease, close monitoring is warranted,
with consideration of potential coronary protective medical therapies.
Joshua Friedland-Little, Ranjit
Aiyagari, Robert J. Gajarski and Kurt
R. Schumacher
Division of Pediatric Cardiology, Department of
Pediatrics, University of Michigan Health Center,
Ann Arbor, MI, USA
Key words: heart transplantation – pediatrics –
Kawasaki disease – coronary aneurysm
Joshua Friedland-Little, MD, University of Michigan
Congenital Heart Center, C.S. Mott Children’s
Hospital, 1540 East Hospital Drive, Ann Arbor, MI
48109-4204, USA
Tel.: +1 734 232 8431
Fax: +1 734 936 9470
E-mail: jmfriedl@med.umich.edu
Accepted for publication 11 July 2012
Background
First described in 1967 in Japan, Kawasaki
disease is an acute, systemic vasculitis of unclear
etiology (1). It is the most common cause of
acquired heart disease in children in the United
States, with coronary artery inflammation and
aneurysm formation developing in 15–25% of
untreated patients (2). Standard treatment of
Kawasaki disease involves IVIG and high-dose
aspirin in the acute phase, with long-term low-
dose aspirin therapy in patients with evidence
of coronary involvement (2). Coronary artery
abnormalities usually develop within six to
eight wk of the onset of illness. The coronary
artery disease is often reversible, with resolution
of coronary artery anomalies seen in approxi-
mately 50% of patients within two yr (3).
Case report
The patient is a three-yr-old girl with a history of
hypoplastic left heart syndrome status post-
hemi-Fontan procedure who underwent ortho-
topic HTx at 18 months of age due to poor right
ventricular function and significant AV valve
regurgitation. Her post-HTx hospital course was
complicated by biventricular failure requiring
VA ECMO for 36 h, from which she completely
recovered. Immunosuppression regimen initially
consisted of tacrolimus and mycophenolate
mofetil, but the patient was subsequently
switched to tacrolimus monotherapy due to per-
sistent EBV viremia. Initial screening coronary
angiography performed two yr after her HTx
revealed a dilated LMCA along with a fusiform
aneurysm of the LAD coronary artery (Fig. 1a).
The RCA also demonstrated coronary ectasia
with diffuse dilation (Fig. 1b). These angiographic
Abbreviations: AV, atrioventricular; EBV, Epstein–Barr
virus; HTx, heart transplantation; IVIG, intravenous immu-
noglobulin; LAD, left anterior descending; LMCA, left
main coronary artery; RCA, right coronary artery; TCAD,
transplant coronary artery disease; VA, venoarterial.
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findings are characteristics of Kawasaki disease,
although the patient did not have any history of
febrile illness consistent with the diagnosis. Lack
of available medical records has precluded inves-
tigating whether the donor, a three-yr-old boy
with head trauma, had any history of febrile ill-
ness prior to organ donation. Review of the
donor echocardiogram, however, revealed that
the LMCA had been prominent and mildly
dilated prior to transplant (Fig. 2). Review of
previous echocardiograms from our institution
revealed that the left and right main coronary
arteries had been significantly dilated one month
after transplant and that the aneurysm of the
LAD had been present at that time as well.
Repeat angiography one yr later has revealed
that the right and left main coronary arteries are
now normal in size. The LAD aneurysm is still
present, but has become smaller. The patient has
continued to do well clinically and is being main-
tained on low-dose aspirin therapy.
Discussion
To our knowledge, this is the first reported case
in which undiagnosed Kawasaki disease in a
pediatric cardiac donor has apparently presented
with coronary artery anomalies in the transplant
recipient. While it is impossible for us to confirm
a diagnosis of Kawasaki disease in the organ
donor given the limited available medical
records, the presence of coronary ectasia in the
donor echocardiogram, as well as the demonstra-
tion of coronary anomalies in the transplanted
heart as early as a month after transplant,
strongly supports this conclusion. Consistent
with the literature, the identified coronary abnor-
malities have regressed with time. Three yr after
transplant, the right and left main coronary
arteries are normal in size. The aneurysm of the
LAD persists, although it is smaller than it was
on angiography one yr prior.
The clinical implications of these findings are
unclear, but there is evidence to suggest that
abnormalities of coronary artery morphology
and function persist following Kawasaki disease
even after any echocardiographic and angio-
graphic changes have resolved. Several groups
have documented persistent intimal thickening fol-
lowing normalization of coronary artery dimen-
sions (4, 5), and there are multiple reports of
coronary endothelial dysfunction in the same
(a) (b)
Fig. 1. (a) Initial screening coronary angiography two yr after transplant revealed a dilated LMCA measuring 4.0 mm
(Z-score +3.9 for body surface area, BSA) and a fusiform aneurysm of the proximal LAD measuring 3.8 mm (Z-score +6.8
for BSA). (b) The proximal RCA was dilated as well, measuring 3.6 mm (Z-score +4.9 for BSA).
Fig. 2. Donor echocardiogram performed shortly prior to
transplant revealed that the LMCA was prominent and
mildly dilated at that time, measuring 3.2 mm (Z-score +2.5
for body surface area).
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setting (6–8). These findings have led to specula-
tion that patients with coronary involvement
related to Kawasaki disease, even those in
whom all visible lesions have regressed, may be
at risk of premature atherosclerotic coronary
artery disease. Given the link between coronary
endothelial dysfunction and the development of
TCAD (9), it is worrisome that the effects of
Kawasaki disease on the graft in this case may
also increase the risk of early TCAD.
Based upon the AHA guidelines for Kawasa-
ki disease, this patient would fall in risk level III
(small-to-medium coronary artery aneurysm).
Recommended follow-up for patients in this
risk class includes low-dose aspirin therapy and
biannual non-invasive screening for coronary
ischemia (stress test or myocardial perfusion
scan) (2). Given the unknown long-term conse-
quences of Kawasaki disease on coronary arter-
ies in a transplanted heart, we have opted to
monitor the patient with yearly coronary angi-
ography for the time being, in addition to
standard low-dose aspirin therapy. We will also
consider early initiation of statin therapy and
transition to sirolimus for its potential coronary
protective effects (10).
Conclusion
To our knowledge, this is the first reported case
of apparent undiagnosed Kawasaki disease in a
cardiac organ donor manifesting with coronary
artery ectasia and aneurysm formation in the
organ recipient. Consistent with the natural
history of Kawasaki disease, the right and left
coronary artery ectasia has resolved three yr
after transplant, but a small aneurysm of the
LAD persists. Based on numerous reports of
persistent coronary artery intimal thickening
and endothelial dysfunction in the aftermath of
Kawasaki disease, we believe that this patient
may be at increased risk of developing early
TCAD. Continued close monitoring is war-
ranted, along with standard medical coronary
protective therapy.
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